You can buy or sell VRTX and other stocks, options, and ETFs commission-free!
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. The listed name for VRTX is Vertex Pharmaceuticals Incorporated Common Stock.
52 Week High
52 Week Low
$2.32 per share
Available Oct 29, After Hours